Shineway Pharmaceutical Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 59.1 | 54.9 | 53.4 |
| Net Investing Cash Flow | (5.2) | (7.3) | 1.4 |
| Net Financing Cash Flow | (48.3) | (26.0) | (23.3) |
| Net Change in Cash | 5.7 | 21.6 | 31.5 |
| Depreciation & Amortization | -- | -- | 3.8 |
| Capital Expenditures | (12.3) | (11.8) | (3.0) |
| Cash Dividends Paid | (48.3) | (26.0) | (23.3) |
© 2009 Morningstar, Inc. Financial Data provided by
